Activity and Safety of Tegafur, Gimeracil, and Oteracil Potassium for Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis

Figure 4

Forest plots of the comparison between S-1 treatment and non-S-1 treatment in the subgroups: (a) locally advanced NPC RR, (b) advanced NPC RR, (c) chemotherapy RR, (d) RC vs R RR, (e) RC RR, and (f) S-1 vs. 5-Fu RR. RR, response rate; chemotherapy, treatment of the experimental and control groups with chemotherapy; RC vs. R, chemotherapy concomitant with radiotherapy (S-1 treatment) and radiotherapy alone (non-S-1 treatment); RC, treatment of the experimental and control groups with chemoradiotherapy; 5-Fu, 5-fluorouracil; S-1 vs. 5-Fu, treatment of the experimental group with S-1 and the control group with 5-Fu.

(a)

(b)

(c)

(d)

(e)

(f)